Arthur Yushuva, MD
Colon & Rectal Surgery · Rego Park, NYNPI 1841433760
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,000 of the $8,673 with a category attached, or 69.2%. Intuitive Surgical accounts for 76.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $4,295 and has fallen 97.3% since, to $114 in 2024.
Across 69 payments — averaging $125.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Davol Inc.$695
- C. R. Bard, Inc. & Subsidiaries$369
- Merck$352
- Medtronic$88
- Johnson & Johnson$66
- plus $460 from 15 others
What the payments were for
- Consulting fees$511%
- Travel & lodging$3023%
- Food & beverage$2,31927%
- Education$6,00069%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $6,643 |
| Davol Inc. | 10 | $695 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $369 |
| Merck | 18 | $352 |
| Medtronic | 4 | $88 |
| Johnson & Johnson | 3 | $66 |
| Applied Medical Resources Corporation | 1 | $60 |
| Coloplast | 2 | $52 |
| Baxter Healthcare | 1 | $45 |
| Axonics, Inc. | 2 | $43 |
| Innovation Technologies Inc | 2 | $37 |
| TEI Biosciences Inc | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $21 |
| Avanos Medical | 1 | $19 |
| Acacia Pharma Inc | 1 | $19 |
| AbbVie | 1 | $19 |
| Acell, Inc. | 1 | $18 |
| Advanced Oxygen Therapy Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,230
- PHASIX$614
- Phasix Mesh$143
How this compares
$8,673 in reported general payments places this provider in the 80th percentile of 177 colon & rectal surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 32 | $190 |
| Metronidazole | 26 | $94 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $88 |
| Levofloxacin | 24 | $27 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Rego Park
- David RivadeneiraWoodbury$271K
- Jerald WishnerMount Kisco$246K
- Sanghyun KimNew York$154K
- Ziad KronfolWest Nyack$81K
- Lynn OconnorHuntington$63K
- Mehraneh JafariNew York$50K
- Jeffrey MilsomNew York$42K
- Stephen RauhRochester$37K
- Evelyn IrizarryBronx$26K
- David SchwartzbergNew York$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.